We are delighted to invite exhibitors to join us at EPSC 2027, as the European Peptide Synthesis Conference continues its trajectory of growth and international impact.

Building on the success and increasing attendance of previous editions, EPSC 2027 will offer expanded exhibition capacity to accommodate a broader range of technology providers, solution partners, and industry innovators. The move to a larger, purpose-designed venue enables enhanced exhibition logistics, improved delegate flow, and greater visibility for our commercial partners.

EPSC has become a key meeting point for peptide scientists, pharmaceutical innovators, CROs, and technology leaders across Europe and beyond. With increased floor space, dedicated networking zones, and integrated scientific programming, exhibitors in 2027 will benefit from:

• Greater stand availability and flexibility in booth configuration
• Increased delegate engagement opportunities
• Improved integration between exhibition and scientific sessions
• Expanded networking and evening event participation



As the conference community continues to grow, EPSC 2027 represents our most ambitious and commercially dynamic edition to date. We look forward to welcoming both returning partners and new exhibitors to Malaga for what promises to be our largest and most impactful event yet.